FOLLOWING record growth in 2022, dermatology brand Galderma has reached the US$2 billion net sales mark in the first half of 2023, up 6.9% year-on-year, ahead of the company's expectations.
PHARMACEUTICAL Benefits Scheme (PBS) data for the financial year 2024-25 has revealed some new entries in the top 10 most expensive drugs in terms of cost to government, with COVID antivirals dropping out.
THE Australian Health Practitioner Regulation Agency (Ahpra) and National Boards have announced changes to the way sexual misconduct is reported on the public register of practitioners, commencing early next year.
HOLIDAY makers are being urged to stay vigilant against mosquito bites this summer, as warmer temperatures heighten the risk of Ross River virus outbreaks, especially in riverland and coastal regions.